[68Ga]/[177Lu]P17-087: A potential theranostic agent targeting PSMA expressing tumor

被引：0
|
作者：
Kung, Hank [1 ]
Choi, Seok Rye [2 ]
Zha, Zzhihao [1 ]
Ploessl, Karl [1 ]
Alexoff, David [3 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] Five Eleven Pharma, Philadelphia, PA USA
[3] Five Eleven Pharma Inc, Philadelphia, PA USA
来源：
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS | 2019年 / 62卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
O-71
引用
收藏
页码：S99 / S100
页数：2
相关论文
共 50 条
  • [1] Novel [68Ga/177Lu]Ga/Lu-AAZTA-PSMA-093 as PSMA targeting agent for diagnosis and radiotherapy
    Liu, Tianqing
    Wang, Ran
    Jin, Wenbin
    Luo, Yang
    Hong, Haiyan
    Zhao, Ruiyue
    Li, Linlin
    Yan, Li
    Qiao, Jinping
    Zhu, Lin
    Kung, Hank
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 2023, 126 : S304 - S305
  • [2] Theranostic Agent Targeting Bone Metastasis: A Novel [68Ga]Ga/[177Lu]Lu-DOTA-HBED-bisphosphonate
    Jin, Wenbin
    Zhao, Ruiyue
    Wang, Ran
    Choi, Seok Rye
    Ploessl, Karl
    Alexoff, David
    Wu, Zehui
    Zhu, Lin
    Kung, Hank F.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (06) : 4793 - 4803
  • [3] Novel [68Ga/177Lu]Ga/Lu-AZ-093 as PSMA-Targeting Agent for Diagnosis and Radiotherapy
    Wang, Ran
    Jin, Wenbin
    Luo, Yang
    Hong, Haiyan
    Zhao, Ruiyue
    Li, Linlin
    Yan, Li
    Qiao, Jinping
    Ploessl, Karl
    Zhu, Lin
    Kung, Hank F.
    [J]. MOLECULAR PHARMACEUTICS, 2024, 21 (07) : 3256 - 3267
  • [4] Preparation and Preliminary Evaluation of Neurotensin Radiolabelled with 68Ga and 177Lu as Potential Theranostic Agent for Colon Cancer
    Leonte, Radu Anton
    Chilug, Livia Elena
    Serban, Radu
    Mustaciosu, Cosmin
    Raicu, Alina
    Manda, Gina
    Niculae, Dana
    [J]. PHARMACEUTICS, 2021, 13 (04)
  • [5] Experimental study of 68Ga/177Lu PSMA I&T: A novel PSMA inhibitor for theranostic of prostate cancer
    Zhang, Lulu
    Zhang, Pengjun
    Wang, Feng
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2019, 62 : S528 - S529
  • [6] Novel developed HPLC analyses of [68Ga]Ga/[177Lu]Lu-EDTMP and [68Ga]Ga/[177Lu]Lu-DOTA-Zoledronate
    Eryilmaz, Kurtulus
    Bakar, Hasan Ensar
    Kilbas, Benan
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2022, 65 (07): : 178 - 186
  • [7] Preliminary Evaluation of Iron Oxide Nanoparticles Radiolabeled with 68Ga and 177Lu as Potential Theranostic Agents
    Salvanou, Evangelia-Alexandra
    Kolokithas-Ntoukas, Argiris
    Liolios, Christos
    Xanthopoulos, Stavros
    Paravatou-Petsotas, Maria
    Tsoukalas, Charalampos
    Avgoustakis, Konstantinos
    Bouziotis, Penelope
    [J]. NANOMATERIALS, 2022, 12 (14)
  • [8] Preclinical development of a novel [68Ga]Ga-/[177Lu]Lu-labeled agent for PSMA-targeted imaging and therapy
    Wu, Yitian
    Zhang, Xiaojun
    Zhou, Haoxi
    Zhang, Jinming
    [J]. JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 2022, 331 (06) : 2705 - 2717
  • [9] Preclinical development of a novel [68Ga]Ga-/[177Lu]Lu-labeled agent for PSMA-targeted imaging and therapy
    Yitian Wu
    Xiaojun Zhang
    Haoxi Zhou
    Jinming Zhang
    [J]. Journal of Radioanalytical and Nuclear Chemistry, 2022, 331 : 2705 - 2717
  • [10] Potential airborne releases of 68Ga and 177Lu: a method of preventive assessment
    Marengo, M.
    Rubow, S.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S734 - S734
12345